Literature DB >> 3256305

Albumin abuse in intensive care medicine.

A F Grootendorst1, M G van Wilgenburg, P H de Laat, B van der Hoven.   

Abstract

Albumin is a much abused and expensive drug in intensive care units. One of the motivations for its use is the prevention of pulmonary edema by enhancing the colloid osmotic pressure (COP). Fear of pulmonary edema has led to the formation of a magic (arbitrary) albumin value varying from one intensive care unit to another. Many intensive care units start substituting albumin when it is below 25 g/l. The objective of this paper is to look at the rationale of this policy. Our results show that in intensive care patients, with a variety of primary diagnoses, a poor correlation exists between COP and serum albumin concentration (r = 0.56; p less than 0.001). To get an index of the colloid osmotic status of the I. C.-patient measuring albumin concentration is useless and COP should be measured instead. From 19 patients with a COP in the 15.0-20.0 mmHg range (corresponding albumin range: 12.0-25.0 g/l) and from 10 patients with a COP in the 11.6-15.0 mmHg range (corresponding albumin range 10.5-19.2 g/l) none developed pulmonary edema. It is questionable if expensive, scarce albumin is the drug of choice with which to increase COP, for the mean increase (+/- SD) in COP after infusion of 100 grams albumin is 2.2 (+/- 1.5) mmHg (p less than 0.001). Adopting a COP action level of 15 mmHg can lead to considerable savings.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3256305     DOI: 10.1007/bf00263529

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  7 in total

1.  Colloid oncotic pressure: clinical significance.

Authors:  M H Weil; R J Henning; V K Puri
Journal:  Crit Care Med       Date:  1979-03       Impact factor: 7.598

2.  [Respiratory insufficiency, colloidal-osmotic pressure and albumin therapy].

Authors:  P Lundsgaard-Hansen; E Pappova; J Kollar; M Kollar
Journal:  Infusionstherapie       Date:  1974-12

3.  Comparison of measured and calculated colloid osmotic pressure of serum and pulmonary edema fluid in patients with pulmonary edema.

Authors:  C L Sprung; S K Isikoff; M Hauser; B R Eisler
Journal:  Crit Care Med       Date:  1980-11       Impact factor: 7.598

4.  Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions.

Authors:  M T Haupt; E C Rackow
Journal:  Crit Care Med       Date:  1982-03       Impact factor: 7.598

5.  Resuscitation in hypovolemia and shock: a prospective study of hydroxyethyl starch and albumin.

Authors:  V K Puri; M Howard; B B Paidipaty; S Singh
Journal:  Crit Care Med       Date:  1983-07       Impact factor: 7.598

6.  Hemodynamic comparison of albumin and hydroxyethyl starch in postoperative cardiac surgery patients.

Authors:  R A Moggio; C C Rha; E D Somberg; P I Praeger; R W Pooley; G E Reed
Journal:  Crit Care Med       Date:  1983-12       Impact factor: 7.598

7.  The direct measurement of plasma colloid osmotic pressure is superior to colloid osmotic pressure derived from albumin or total protein.

Authors:  S A Barclay; D Bennett
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

  7 in total
  12 in total

1.  Wonderful albumin?

Authors:  N Soni
Journal:  BMJ       Date:  1995-04-08

2.  'What's the serum albumin?'.

Authors:  N Williams; A D Scott
Journal:  Ann R Coll Surg Engl       Date:  1998-03       Impact factor: 1.891

3.  Reliability of cardiac output estimation by thermodilution.

Authors:  A Versprille
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

Review 4.  Exploding the albumin myth.

Authors:  M M Tjoeng; A K Bartelink; L G Thijs
Journal:  Pharm World Sci       Date:  1999-02

5.  Application of Unit-Level Cost Transparency, Education, Enhanced Audit, and Feedback of Anonymized Peer Ranking to Promote Judicious Use of 25% Albumin in Critical Care Units.

Authors:  Chiedozie I Udeh; Matthew Wanek; Belinda L Udeh; J Steven Hata
Journal:  Hosp Pharm       Date:  2019-02-10

6.  Volume replacement strategies on intensive care units: results from a postal survey.

Authors:  J Boldt; M Lenz; B Kumle; M Papsdorf
Journal:  Intensive Care Med       Date:  1998-02       Impact factor: 17.440

7.  Mechanisms of postoperative prolonged plasma volume expansion with low molecular weight hydroxethy starch (HES 200/0.62, 6%).

Authors:  A C Degrémont; M Ismaïl; M Arthaud; B Oulare; O Mundler; M Paris; J F Baron
Journal:  Intensive Care Med       Date:  1995-07       Impact factor: 17.440

Review 8.  Debate: Albumin administration should be avoided in the critically ill.

Authors:  T B Pulimood; G R Park
Journal:  Crit Care       Date:  2000       Impact factor: 9.097

9.  Weakening Impact of Excessive Human Serum Albumin (eHSA) on Cisplatin and Etoposide Anticancer Effect in C57BL/6 Mice with Tumor and in Human NSCLC A549 Cells.

Authors:  Zhen Yang; Ting Zhou; Yuanchi Cheng; Mingming Li; Xianglin Tan; Feng Xu
Journal:  Front Pharmacol       Date:  2016-11-15       Impact factor: 5.810

10.  Hemostatic Findings in Ascitic Fluid: A Cross-Sectional Study in 70 Dogs.

Authors:  A Zoia; M Drigo; C J Piek; P Simioni; M Caldin
Journal:  J Vet Intern Med       Date:  2016-11-16       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.